- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
Détention brevets de la classe C12N 15/85
Brevets de cette classe: 10718
Historique des publications depuis 10 ans
|
584
|
630
|
764
|
1014
|
1013
|
885
|
1000
|
1025
|
1034
|
486
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4233 |
372 |
| The Regents of the University of California | 19839 |
213 |
| Massachusetts Institute of Technology | 10019 |
154 |
| The Trustees of the University of Pennsylvania | 4315 |
143 |
| President and Fellows of Harvard College | 5952 |
133 |
| The Broad Institute, Inc. | 1788 |
95 |
| The Board of Trustees of the Leland Stanford Junior University | 6380 |
94 |
| Sangamo Therapeutics, Inc. | 415 |
75 |
| Kymab Limited | 250 |
63 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 174 |
59 |
| The General Hospital Corporation | 4710 |
58 |
| The Johns Hopkins University | 5642 |
57 |
| University of Massachusetts | 2222 |
56 |
| Duke University | 3063 |
54 |
| Novartis AG | 10883 |
52 |
| Modernatx, Inc. | 1260 |
52 |
| Board of Regents, The University of Texas System | 5754 |
48 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
47 |
| Yale University | 2363 |
45 |
| Memorial Sloan-Kettering Cancer Center | 1913 |
41 |
| Autres propriétaires | 8807 |